Page last updated: 2024-11-04

1-propanol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1-Propanol: A colorless liquid made by oxidation of aliphatic hydrocarbons that is used as a solvent and chemical intermediate. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

propan-1-ol : The parent member of the class of propan-1-ols that is propane in which a hydrogen of one of the methyl groups is replaced by a hydroxy group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID1031
CHEMBL ID14687
CHEBI ID28831
MeSH IDM0000657

Synonyms (165)

Synonym
bdbm36153
propanol-1
n-propyl alkohol
n-propan-1-ol
nsc-30300
propanolen
wln: q3
alcool propylique
nsc30300
propanoli
1-propyl alcohol
alcool propilico
propanole
propylowy alkohol
propylic alcohol
n-propylalkohol
ethyl carbinol
CHEBI:28831 ,
142583-61-7
policosanol
propyl alcohol (natural)
ai3-16115
alcool propylique [french]
propanol, 1-
alcohol, propyl
ccris 3202
einecs 200-746-9
fema no. 2928
alcool propilico [italian]
nsc 30300
fema number 2928
propyl alcohol, normal
hsdb 115
albacol
propanole [german]
caswell no. 709a
n-propyl alkohol [german]
propanoli [italian]
epa pesticide chemical code 047502
propylowy alkohol [polish]
brn 1098242
propanolen [dutch]
un1274
inchi=1/c3h8o/c1-2-3-4/h4h,2-3h2,1h
propane-1-ol
osmosol extra
71-23-8
propyl alcohol
optal
C05979
1-hydroxypropane
propan-1-ol
n-propyl alcohol
un 1274
1-propanol
ethylcarbinol
propylalcohol
PROPANOL ,
n-propanol
POL ,
1-proponol
1-propanol, >=99%, fg
1-propanol, natural, >=98%, fg
DB03175
1-propanol, anhydrous, 99.7%
AKOS000249219
BMSE000446
CHEMBL14687
P0491
LMFA05000101
A837125
62309-51-7
dtxsid2021739 ,
tox21_302440
NCGC00255163-01
dtxcid001739
cas-71-23-8
1 propanol
n-propanol or propyl alcohol, normal
n-propanol or propyl alcohol, normal [un1274] [flammable liquid]
ec 200-746-9
96f264o9sv ,
4-01-00-01413 (beilstein handbook reference)
unii-96f264o9sv
FT-0608280
FT-0627482
FT-0608281
propanol [who-dd]
propyl alcohol [inci]
propyl alcohol [mart.]
1-propanol [usp-rs]
propyl alcohol [mi]
propyl alcohol [fhfi]
n-propanol [hsdb]
propanol [ep monograph]
propyl alcohol, n-
propyl alcohol (propanol)
propyl alcohol [fcc]
propyl-3,3,3-d3 alcohol
propyl-d7 alcohol
propyl-1,1-d2 alcohol
STL264225
normal propyl alcohol
ethyl methanol
nproh
proh
n-propylalcohol
n-proh
3-propanol
hopr
normal propanol
propylan-propyl alcohol
n-c3h7oh
propanol-1,1,2,2-d4
70907-80-1
89603-83-8
188894-71-5
mfcd00002941
5vq ,
1-propanol, hplc grade
1-propanol, spectrophotometric grade
1-propanol, anhydrous
F0001-1829
1-propanol, analytical standard
1-propanol, purum, >=99.0% (gc)
1-propanol, >=99% (gc), purum
1-propanol, for inorganic trace analysis, >=99.8%
1-propanol, united states pharmacopeia (usp) reference standard
1-propanol, saj first grade, >=99.0%
1-propanol, hplc grade, >=99.5%
1-propanol, >=99.80%
1-propanol, for hplc, >=99.9%
1-propanol, >=99%
1-propanol, puriss. p.a., reag. ph. eur., >=99.5% (gc)
1-propanol, acs reagent, >=99.5%
1-propanol, jis special grade
1-propanol, for hplc, >=99.5%
1-propanol, lr, >=99%
1-propanol, uv hplc spectroscopic, 99.0%
1-propanol, p.a., 99.5%
1-propanol, pharmaceutical secondary standard; certified reference material
1-propanol, ar, >=99.5%
propanol; propan-1-ol
J-505102
hydroxypropane
n-propanol acs grade
1-propanol 100 microg/ml in acetonitrile
1-propanol-d1
Q14985
AMY11110
propyl-2-d1 alcohol
EN300-19337
hydroxypropyl cellulose-sl (hpc-sl)
propyl-1,1,3,3,3-d5 alcohol
pesticide code: 047502
propyl alcohol (mart.)
caswell no 709a
propanol (ep monograph)
astm method d7059 calibration mixture 6 25-500 microg/ml in toluene
astm method d7059 calibration mixture 4 150-500 microg/ml in toluene
astm method d7059 calibration mixture 3 300-500 microg/ml in toluene
astm method d7059 calibration mixture 2 500-600 microg/ml in toluene
astm method d7059 calibration mixture 7 5-500 microg/ml in toluene
astm method d7059 calibration mixture 5 100-500 microg/ml in toluene
astm method d7059 calibration mixture 1 500-1200 microg/ml in toluene

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" In rats pretreated with 278 mg of EP/kg the acute LD50 of 1,1-DCE was reduced by a factor of 5 (to less than 40 mg/kg) and doses of 1,1-DCE as low as 12."( Enhancement of 1,1-dichloroethylene toxicity by pretreatment of fasted male rats with 2,3-epoxypropan-1-ol.
Andersen, ME; Jenkins, LJ; Jones, RA,
)
0.13
" The greater potency of PMC and T4P compared to CPA is likely the result of these compounds bypassing important detoxification steps, therefore, more of the parent compound reaches the ovary as the toxic metabolite."( Phosphoramide mustard is responsible for the ovarian toxicity of cyclophosphamide.
Mattison, DR; Plowchalk, DR, 1991
)
0.28
" AA is inactive per se and its toxic expression is modulated by its alcohol dehydrogenase (ADH) oxidation to form acrolein, which is responsible for the hepatotoxic action."( Aspects of allyl alcohol toxicity.
Atzori, L; Congiu, L; Dore, M, 1989
)
0.28
" The possibility that methoxyflurane increases alcohol dehydrogenase-dependent oxidation of allyl alcohol to acrolein, the proposed toxic metabolite, was evaluated by measuring the rate of acrolein formation in the presence of allyl alcohol and liver cytosol."( Methoxyflurane enhances allyl alcohol hepatotoxicity in rats. Possible involvement of increased acrolein formation.
Barsotti, DA; Dent, JG; Kershaw, WC; Lage, GL; Leonard, TB,
)
0.13
" This protective effect of calcium was decreased at higher concentrations of the toxic compounds."( Extracellular calcium alleviates cell toxicity due to hepatotoxins that induce lipid peroxidation, but has no effect on toxins that do not cause lipid peroxidation. A study in isolated rat hepatocytes.
Dogterom, P; Kroese, ED; Mulder, GJ; Nagelkerke, JF, 1989
)
0.28
" The results suggest that the inactivation of protein thiol groups is critical for allyl alcohol toxicity whereas lipid peroxidation is not essential to the toxic process."( Relative contributions of protein sulfhydryl loss and lipid peroxidation to allyl alcohol-induced cytotoxicity in isolated rat hepatocytes.
Hormann, VA; Moore, DR; Rikans, LE, 1989
)
0.28
"2) that decreases cellular levels of glutathione markedly] were sensitized to the toxic effects of CdCl2."( Glutathione, a first line of defense against cadmium toxicity.
Anderson, ME; Meister, A; Singhal, RK, 1987
)
0.27
" The toxicity was prevented by inhibitors of alcohol dehydrogenase and augmented by the aldehyde dehydrogenase inhibitor disulfiram, suggesting that the toxic metabolite was the reactive aldehyde acrolein."( Mechanism of allyl alcohol toxicity and protective effects of low-molecular-weight thiols studied with isolated rat hepatocytes.
Ohno, Y; Ormstad, K; Orrenius, S; Ross, D, 1985
)
0.27
"The nitrocompounds 3-nitropropanol (NPOH) and 3-nitropropionic acid (NPA) were shown to be equally toxic when injected intraperitoneally into male Wistar rats."( Effect of alcohol and aldehyde dehydrogenase inhibitors on the toxicity of 3-nitropropanol in rats.
Majak, W; Muir, AD; Pass, MA; Yost, GS, 1985
)
0.27
" These results indicate that acrolein is the toxic metabolite responsible for the renal cell injury following exposure to allyl alcohol, and unless immediately inactivated acrolein interacts with critical nucleophilic sites of the cell and initiates cell injury."( Allyl alcohol toxicity in isolated renal epithelial cells: protective effects of low molecular weight thiols.
Jones, TW; Ohno, Y; Ormstad, K, 1985
)
0.27
" The oral LD50 was calculated by the probit method (Finney, 1971) as 110 (100-120) mg/kg for male rats and 55 (50-60) mg/kg for female rats."( Acute oral toxicity as LD50 (mg/kg) of propargyl alcohol to male and female rats.
Archer, TE, 1985
)
0.27
" These results lend support to the concept that a NDMA demethylase is responsible for the activation of NDMA in vivo to a toxic intermediate, and induction of this enzyme activity potentiates NDMA hepatotoxicity."( Potentiation of the hepatotoxicity of N-nitrosodimethylamine by fasting, diabetes, acetone, and isopropanol.
Chung, HR; Lorr, NA; Miller, KW; Yang, CS, 1984
)
0.27
"We examined the effect of a toxic concentration of allyl alcohol (0."( Allyl alcohol cytotoxicity in isolated rat hepatocytes: mechanism of cell death does not involve an early rise in cytosolic free calcium.
Cai, Y; Hornbrook, KR; Rikans, LE, 1994
)
0.29
" Overall, policosanol was well tolerated throughout the study and no toxic symptoms were observed."( Toxicity of policosanol in beagle dogs: one-year study.
Alemán, CL; Capote, A; Gámez, R; García, M; Hernández, C; Más, R; Mesa, AR; Noa, M; Rodeiro, I, 1994
)
0.29
" The results suggest that initial events in the toxic process are reversible, and that DTT can prevent cytotoxicity if added to hepatocytes before irreversible damage occurs; however, the mechanism by which DTT exerts its protection is not clear."( Dithiothreitol reversal of allyl alcohol cytotoxicity in isolated rat hepatocytes.
Cai, Y; Rikans, LE, 1994
)
0.29
" Bromoacetaldehyde was more toxic (EC(50)60 mu M, 2 hr) and bromoacetic acid was less toxic (EC(50)150 mu M, 2 hr)."( The involvement of cytochrome P4502E1 in 2-bromoethanol-induced hepatocyte cytotoxicity.
Khan, S; O'Brien, PJ; Sood, C, 1996
)
0.29
" In vitro, but not in vivo, verapamil inhibited the activity of alcohol dehydrogenase (ADH), the key enzyme in the conversion of AA into the toxic metabolite acrolein."( Effect of verapamil on allyl alcohol hepatotoxicity.
Atzori, L; Congiu, L, 1996
)
0.29
" Coumarin produced concentration-dependent toxic effects in rat and guinea-pig liver slices, whereas Cynomolgus monkey and human liver slices were relatively resistant, especially at low coumarin concentrations."( Comparison of the toxicity of allyl alcohol, coumarin and menadione in precision-cut rat, guinea-pig, cynomolgus monkey and human liver slices.
Beamand, JA; Lake, BG; Mistry, H; Price, RJ; Renwick, AB; Wield, PT, 1996
)
0.29
" Rats were pretreated with LPS (100 micrograms/kg) 2 hr before treatment with a minimally toxic dose of allyl alcohol mg/kg), and liver toxicity was assessed 18 hr later from activity of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in plasma and from histologic changes in liver sections."( Bacterial endotoxin enhances the hepatotoxicity of allyl alcohol.
Brown, AP; Ganey, PE; Grimes, SD; Schultze, AE; Sneed, RA, 1997
)
0.3
" No signs of toxic effects related to the test material were observed in the dams F0 during pregnancy and lactation."( Evaluation of peri- and post-natal toxicity of Policosanol in rats.
Garcia, H; Rodríguez, MD, 1998
)
0.3
" In addition, the effect of toxic compounds on the swimming speed was assessed relative to application as a toxicity sensor."( Swimming characteristics of magnetic bacterium, Magnetospirillum sp. AMB-1, and implications as toxicity measurement.
Park, TH; Seong, S, 2001
)
0.31
" However, policosanol, a mixture of long-chain aliphatic alcohols extractable from sugar cane wax, has shown cholesterol-lowering potency comparable to that of statins, and yet appears to be devoid of toxic risk."( Policosanol safely down-regulates HMG-CoA reductase - potential as a component of the Esselstyn regimen.
McCarty, MF, 2002
)
0.31
" Both treatments were safe and well tolerated."( Comparison of the efficacy, safety and tolerability of original policosanol versus other mixtures of higher aliphatic primary alcohols in patients with type II hypercholesterolemia.
Alvarez, E; Castaño, G; Fernández, J; Fernández, L; Illnait, J; Lezcay, M; Mas, R; Mesa, M, 2002
)
0.31
" No adverse effects were detected when liver and muscular enzymes (AST, ALT, and CK) were determined."( The treatment of hypercholesterolemic children: efficacy and safety of a combination of red yeast rice extract and policosanols.
Abello, F; Baracco, V; Guardamagna, O; Martino, F; Stasiowska, B, 2011
)
0.37
" Results indicate this strategy as an effective, safe and well tolerated in a short-term trial."( The treatment of hypercholesterolemic children: efficacy and safety of a combination of red yeast rice extract and policosanols.
Abello, F; Baracco, V; Guardamagna, O; Martino, F; Stasiowska, B, 2011
)
0.37
" The secondary endpoints were 6-month major adverse cardiac events (MACE), which included cardiac death, nonfatal myocardial infarction, or ischemic symptoms driven target vessel revascularization."( Safety and efficacy of policosanol in patients with high on-treatment platelet reactivity after drug-eluting stent implantation: two-year follow-up results.
Guo, L; Han, Y; Li, Y; Liu, X; Wang, X; Wang, Y; Xu, K; Zang, H; Zhao, W, 2016
)
0.43
" Major adverse cardiac events occurred in 4 (8."( Safety and efficacy of policosanol in patients with high on-treatment platelet reactivity after drug-eluting stent implantation: two-year follow-up results.
Guo, L; Han, Y; Li, Y; Liu, X; Wang, X; Wang, Y; Xu, K; Zang, H; Zhao, W, 2016
)
0.43
"This study aimed to systematically investigate whether sugarcane policosanol was effective and safe on dyslipidemia."( Efficacy and safety of sugarcane policosanol on dyslipidemia: A meta-analysis of randomized controlled trials.
Chen, G; Dong, H; Fang, K; Gong, J; Hu, M; Huang, Z; Jiang, S; Li, J; Lu, F; Qin, X; Wang, D; Yuan, F; Zhao, Y, 2018
)
0.48
" The adverse effects analysis demonstrated that sugarcane policosanol was safer than the control agents."( Efficacy and safety of sugarcane policosanol on dyslipidemia: A meta-analysis of randomized controlled trials.
Chen, G; Dong, H; Fang, K; Gong, J; Hu, M; Huang, Z; Jiang, S; Li, J; Lu, F; Qin, X; Wang, D; Yuan, F; Zhao, Y, 2018
)
0.48
"The new protocol for chlorhexidine application permits surgical hand preparation with chlorhexidine, as a safe alternative to alcohol solutions, because it meets the standards defined by EN 12791."( Surgical hand preparation with chlorhexidine soap or povidone iodine: new methods to increase immediate and residual effectiveness, and provide a safe alternative to alcohol solutions.
Herruzo, R; Vizcaino, MJ; Yela, R, 2018
)
0.48
" Safety was assessed by adverse events and laboratory parameters."( Efficacy and Safety of Policosanol Plus Fenofibrate Combination Therapy in Elderly Patients with Mixed Dyslipidemia: A Randomized, Controlled Clinical Study.
Chen, SY; Fang, NY; Jiang, H; Jiao, QP; Lu, J; Sheng, J; Wang, HY; Zheng, SB, 2018
)
0.48
" There were no serious adverse events or significant changes in laboratory variables after any of the treatment regimens."( Efficacy and Safety of Policosanol Plus Fenofibrate Combination Therapy in Elderly Patients with Mixed Dyslipidemia: A Randomized, Controlled Clinical Study.
Chen, SY; Fang, NY; Jiang, H; Jiao, QP; Lu, J; Sheng, J; Wang, HY; Zheng, SB, 2018
)
0.48
"Blends of biodiesel and high-carbon alcohols have the potential to increase the rate of biofuel use in diesel engines, while reducing harmful and toxic compounds such as polycyclic aromatic hydrocarbons (PAHs)."( Fuel effects on PAH formation, toxicity and regulated pollutants: Detailed comparison of biodiesel blends with propanol, butanol and pentanol.
Donaldson, B; Vigil, FM; Yilmaz, N, 2022
)
0.72

Pharmacokinetics

ExcerptReferenceRelevance
" Pharmacokinetic analysis is presented, as well as a brief literature review of diagnosis and management."( Isopropanol ingestion: case report with pharmacokinetic analysis.
Fraser, GL; Gaudet, MP, 1989
)
0.28
"The purpose of this investigation was to 1) compare the performance of proton nuclear magnetic resonance spectroscopy to gas chromatography head-space analysis in the measurement of serum isopropanol and its metabolite, acetone, obtained during a simulated overdose, and 2) compare pharmacokinetic parameters obtained using the two analytical techniques."( Measurement of serum isopropanol and the acetone metabolite by proton nuclear magnetic resonance: application to pharmacokinetic evaluation in a simulated overdose model.
Ackerman, BH; Fuller, GL; Monaghan, MS; Olsen, KM; Pappas, AA; Porter, WH, 1995
)
0.29
"This study investigated the pharmacokinetic and pharmacodynamic interactions of echinacea and policosanol with warfarin in healthy subjects."( Pharmacokinetic and pharmacodynamic interactions of echinacea and policosanol with warfarin in healthy subjects.
Abdul, MI; Day, RO; Jiang, X; Lehmann, RP; Liauw, WS; Matthias, A; McLachlan, AJ; Roufogalis, BD; Williams, KM; Xu, H, 2010
)
0.36
" Pharmacodynamic (INR, platelet activity) and pharmacokinetic (warfarin enantiomer concentrations) end points were evaluated."( Pharmacokinetic and pharmacodynamic interactions of echinacea and policosanol with warfarin in healthy subjects.
Abdul, MI; Day, RO; Jiang, X; Lehmann, RP; Liauw, WS; Matthias, A; McLachlan, AJ; Roufogalis, BD; Williams, KM; Xu, H, 2010
)
0.36
" A pilot pharmacokinetic study of this new β-adrenolytic compound has shown that (-)-(S)-TWo8 is eliminated faster than its antipode."( Enantioselective LC/ESI-MS/MS analysis and pharmacokinetic and tissue distribution study of (2RS)-1-(7-methoxy-1H-indol-4-yloxy)-3-(2-(2-methoxyphenoxy)ethylamino)-propan-2-ol in rats.
Groszek, G; Szymura-Oleksia, J; Walczak, M, 2012
)
0.38
" Here, we developed a physiologically based pharmacokinetic (PBPK) model in rats and humans for the propyl metabolic series including propyl acetate, 1-propanol, propionaldehyde, and propionic acid."( Linking internal dosimetries of the propyl metabolic series in rats and humans using physiologically based pharmacokinetic (PBPK) modeling.
Faber, W; Smith, JN; Smith, JP; Tyrrell, KJ; Weitz, KK, 2020
)
0.76

Compound-Compound Interactions

ExcerptReferenceRelevance
"Comparative molecular field analysis (CoMFA) combined with various physicochemical parameters were used to develop three-dimensional quantitative structure-transportability relationships (3-D QSTR) to predict membrane flux for 108 aromatic and heteroaromatic compounds through polydimethylsiloxane (PDMS) membranes in isopropyl alcohol (IPA)."( Comparative molecular field analysis combined with physicochemical parameters for prediction of polydimethylsiloxane membrane flux in isopropanol.
Liu, R; Matheson, LE, 1994
)
0.29
"The present study was designed to evaluate the effects of dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylene dioxybiphenyl-2,2'-dicarboxylate (PMC) in combination with garlic oil against chemical-induced hepatic injury in rats and mice."( Enhanced effectiveness of dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylene dioxybiphenyl-2,2'-dicarboxylate in combination with garlic oil against experimental hepatic injury in rats and mice.
Chung, HC; Hong, SY; Jung, KH; Kim, SG; Nam, SY, 1995
)
0.29
" Consistent with recent clinical trial data, MP demonstrated an excellent safety profile but produced no significant effects on major lipoproteins when used as monotherapy or when given with concomitant statin therapy."( Modified-policosanol does not reduce plasma lipoproteins in hyperlipidemic patients when used alone or in combination with statin therapy.
Backes, JM; Gibson, CA; Moriarty, PM; Ruisinger, JF, 2011
)
0.37
"To evaluate the effects and safety of policosanol combined with simvastatin on serum lipids and sex hormones in male patients with hyperlipidemia."( [Effects of policosanol combined with simvastatin on serum lipids and sex hormones in male patients with hyperlipidemia].
Gong, X; Tang, M; Wu, SZ, 2013
)
0.39

Bioavailability

ExcerptReferenceRelevance
"0 M, glycerin and propylene glycol increase significantly the intestinal absorption rate of theophylline from the small intestine of anesthetized rats."( Effect of various alcohols on intestinal net water flux and theophylline absorption in rats.
Houston, JB; Levy, G, 1975
)
0.25
"Due to their poor bioavailability after oral administration, the use of gangliosides in medicine is limited to the parenteral route of administration."( In vitro evaluation of nanoparticle formulations containing gangliosides.
Benedetti, LM; Callegaro, L; Couvreur, P; Polato, L, 1994
)
0.29
" Bioavailability was similar for both formulations of propranolol."( Pharmacokinetics of propranolol after single and multiple dosing with sustained release propranolol or propranolol CR (innopran XL) , a new chronotherapeutic formulation.
Frishman, WH; Manowitz, N; Sica, D,
)
0.13
"Following the double-blind, randomized cross-over design for this clinical trial, 20 ml of two different alcohol-containing disinfectants was applied with a 200-cm(2) gauze swab on a skin area, identical in size and location, of 14 healthy volunteers for 10 min to investigate the absorption rate of ethanol and 1-propanol."( Transdermal absorption of ethanol- and 1-propanol-containing hand disinfectants.
Böttrich, JG; Breuer, B; Breuer, M; Brill, FH; Egli-Gany, D; Kirschner, MH; Lang, RA, 2011
)
0.81
"Policosanol is a poorly absorbed nutritional supplement used primarily for cholesterol management."( Modified-policosanol does not reduce plasma lipoproteins in hyperlipidemic patients when used alone or in combination with statin therapy.
Backes, JM; Gibson, CA; Moriarty, PM; Ruisinger, JF, 2011
)
0.37
"Policosanol, a mixture of long-chain alcohols found in animal and plant waxes, has several biological effects; however, it has a bioavailability of less than 10%."( Characterization of rice bran wax policosanol and its nanoemulsion formulation.
Ishaka, A; Mahamud, R; Maznah, I; Umar Imam, M; Zuki, AB, 2014
)
0.4
" However, its bioavailability is low."( Nanoemulsification of Rice Bran Wax Policosanol Enhances Its Cardio-protective Effects via Modulation of Hepatic Peroxisome Proliferator-activated Receptor gamma in Hyperlipidemic Rats.
Imam, MU; Ishaka, A; Ismail, M, 2020
)
0.56

Dosage Studied

ExcerptRelevanceReference
" This metabolite was isolated from the urine of chronically dosed dogs and was identified by mass, nuclear magnetic resonance (NMR), and infrared spectrometry as the N-oxide, 2-phenyl-1-(4-pyridyl)-3-(4-pyridyl-1-oxide)-2-propanol."( Biotransformation of prochiral 2-phenyl-1,3-di(4-pyridyl)-2-propanol to a chiral N-oxide metabolite.
Kolis, SJ; Postma, E; Sasso, GJ; Schwartz, MA; Williams, TH,
)
0.13
" Rats were dosed ip with either 2,3-epoxypropan-1-ol (EP), 1,1,1-trichloropropane-2,3-oxide (TCPO), styrene oxide (SO), cyclohexene oxide (CHO), butadiene monoxide (BMO) or the sulfhydryl reagent, diethylmaleate (DEM) 1 hr before intubation with 1,1-DCE."( Enhancement of 1,1-dichloroethylene toxicity by pretreatment of fasted male rats with 2,3-epoxypropan-1-ol.
Andersen, ME; Jenkins, LJ; Jones, RA,
)
0.13
" These permit the elaboration of dose-response lines for the substances in question, the calculation of median effective doses and the statistical analysis of differences in liver-damaging potency."( Quantitative aspects in the assessment of liver injury.
Plaa, GL, 1976
)
0.26
" No changes in regional contractility occurred with propranolol except for a minimal increase in hypokinesis in one patient at each dosage and equivocal development of a new area of slight hypokinesis in one patient and minimal apex of dyskinesis in another at the higher dosage."( Left ventricular wall motion response to intravenous propranolol.
Dinsmore, RE; Harthorne, JW; Shubrooks, SJ; Zir, LM, 1975
)
0.25
" Cross-tolerance was shown by shifts in dose-response curves for the LRR induced by n-propanol and t-butanol."( Effects of chronic treatment with ethanol on the development of cross-tolerance to other alcohols and pentobarbital.
Kalant, H; Khanna, JM; Lê, AD, 1992
)
0.28
"1 mg/kg po) in male A/JAX mice in a dose-response manner."( Studies on inhibition and induction of metabolism of ethyl carbamate by acetone and related compounds. Evidence for metabolism by cytochromes P-450.
Benz, FW; Hurst, HE; Kemper, RA; Kurata, N; Waddell, WJ,
)
0.13
" Each drug was given separately in a random fashion in fixed dosage for 4 weeks with a washout period of 2 weeks in between the drugs."( The effects of antihypertensive agents on the quality of life in Indian hypertensives.
Kumar, K; Rajan, AG; Somani, PN; Sundar, S, 1991
)
0.28
" The dose-response relationships for activation of phospholipase D and stimulation of thymidine incorporation by PDGF and TPA were comparable."( Phospholipase D activation by the mitogens platelet-derived growth factor and 12-O-tetradecanoylphorbol 13-acetate in NIH-3T3 cells.
Ben-Av, P; Liscovitch, M, 1989
)
0.28
" Monoallyl phthalate (MAP), allyl alcohol, 3-hydroxypropylmercapturic acid (HPMA), and an unidentified polar metabolite (PM) were found in the urine of rats and mice dosed with DAP."( Examination of the differential hepatotoxicity of diallyl phthalate in rats and mice.
Carter, DE; Eigenberg, DA; Schram, KH; Sipes, IG, 1986
)
0.27
" In this case the effective dosage was equivalent to an air volume of 2-5 cbm."( [Biological effect of smog extract. VII. Severe disorders of the cell cycle and its phases in kidney cultures as effected by extract and fractions of smog from a heavily industrialized area].
Behmer, A; Seemayer, NH, 1983
)
0.27
" (Leguminosae), was rapidly hydrolyzed to 3-nitropropanol (NPOH) in the rumen of cattle dosed with timber milkvetch (A."( Absorption of 3-nitropropanol (miserotoxin aglycone) from the compound stomach of cattle.
Majak, W; Muir, AD; Pass, MA; Rode, LM, 1984
)
0.27
" Plasma levels of NPA and inorganic nitrite were higher after dosing with NPOH than with NPA indicating a more rapid rate of uptake of the aglycone."( Absorption of 3-nitropropanol and 3-nitropropionic acid from the digestive system of sheep.
Majak, W; Muir, AD; Pass, MA; Yost, GS, 1984
)
0.27
" In animals dosed with NPOH, the observed NPA decayed at a slower rate than NPOH."( Conversion of 3-nitropropanol (miserotoxin aglycone) to 3-nitropropionic acid in cattle and sheep.
Majak, W; Muir, AD; Pass, MA; Yost, GS, 1984
)
0.27
" Leakage of glutamate oxaloacetate transaminase and glutamate pyruvate transaminase into the cell culture medium was a sensitive indicator of plasma membrane damage by these compounds and a dose-response relationship was observed."( The effects of dimethylnitrosamine and allyl alcohol on primary maintenance cultures of adult rabbit hepatocytes.
Bridges, JW; Chasseaud, LF; Poole, A, 1982
)
0.26
" Dose-response curves were obtained by all 3 assays for those compounds that exhibited mutagenic activity."( Mutagenicity of alkyl glycidyl ethers in three short-term assays.
Coppinger, WJ; McCarroll, N; Oberly, TJ; Piper, CE; Robinson, D; Thompson, ED, 1981
)
0.26
"Rats dosed with cinnamic aldehyde (I) excreted two mercapturic acids in the urine."( Isolation and identification of mercapturic acids of cinnamic aldehyde and cinnamyl alcohol from urine of female rats.
Delbressine, LP; Klippert, PJ; Reuvers, JT; Seuttler-Berlage, F, 1981
)
0.26
" Nearly all dosed rats had malignant neoplasms at one or more sites, while only one control male and one control female had malignant neoplasms."( Toxicity and carcinogenicity of 2,3-dibromo-1-propanol in F344/N rats and B6C3F1 mice.
Abdo, KM; Eustis, SL; Haseman, JK; Mackenzie, WF, 1995
)
0.55
" Thirty rats of each sex per group (P1) were dosed once daily by oral gavage with 0, 100, 500 or 1000 mg isopropanol kg-1 for at least 10 weeks prior to mating."( Two-generation reproduction toxicity study with isopropanol in rats.
Andrews, L; Bevan, C; Beyer, BK; Gardiner, TH; Kapp, RW; Tyler, TR,
)
0.13
" After this period, dosage was doubled to 5 mg twice-a-day for the next 8 weeks and then again doubled to 10 mg twice-a-day."( Effects of successive dose increases of policosanol on the lipid profile of patients with type II hypercholesterolaemia and tolerability to treatment.
Fernández, JC; Fernández, L; Illnait, J; Más, R; Pons, P; Robaina, C; Rodríguez, M, 1994
)
0.29
"Timed-pregnant CD (Sprague-Dawley) rats, 25/group, were dosed orally with aqueous isopropanol (IPA; CAS No."( Developmental toxicity evaluation of isopropanol by gavage in rats and rabbits.
Gardiner, TH; Marr, MC; Masten, LW; McKee, RH; Myers, CB; Slauter, RW; Strother, DE; Tyl, RW; Tyler, TR, 1994
)
0.29
" With this dosing normalization, the 25 mg/kg ideal body weight doses translated to administration of a fixed dose of 13."( Obesity decreases hepatic glutathione concentrations and markedly potentiates allyl alcohol-induced periportal necrosis in the overfed rat.
Corcoran, GB; Jordan, SW; Salazar, DE; Sorge, CL, 1994
)
0.29
" In the initial 3-week dose-response study, as the daily dose of VA increased so did the degree of potentiation of CCl4 hepatotoxicity."( Characterization of vitamin A potentiation of carbon tetrachloride-induced liver injury.
Earnest, DL; elSisi, AE; Hall, P; Sim, WL; Sipes, IG, 1993
)
0.29
" After this period dosage was doubled to 20 mg day-1 for the next 7 days and then again doubled to 40 mg day-1, while the control group received placebo tablets all the time."( Effect of policosanol successive dose increases on platelet aggregation in healthy volunteers.
Arruzazabala, ML; Carbajal, D; Fernández, L; Más, R; Valdés, S,
)
0.13
"The present study demonstrated that policosanol administered within its therapeutic dosage for lowering cholesterol (5 and 10 mg day(-1)), decreased the susceptibility of LDL-C to lipid peroxidation in vitro."( Effects of policosanol treatment on the susceptibility of low density lipoprotein (LDL) isolated from healthy volunteers to oxidative modification in vitro.
Amor, AM; Fernández, JC; González, RM; Jiménez, S; Más, R; Menéndez, R; Rodeiro, I; Zayas, M, 2000
)
0.31
" Policosanol is a cholesterol-lowering drug purified from sugar cane wax with a therapeutic dosage range from 5-20 mg/day."( Comparison of the efficacy and tolerability of policosanol with atorvastatin in elderly patients with type II hypercholesterolaemia.
Alvarez, E; Castaño, G; Fernández, L; Illnait, J; Lezcay, M; Mas, R; Mesa, M, 2003
)
0.32
" This information is critical for optimizing intravitreal dosing which in turn can aid in the design of drug delivery systems."( Disposition of short-chain aliphatic alcohols in rabbit vitreous by ocular microdialysis.
Atluri, H; Mitra, AK, 2003
)
0.32
" Current formulations and dosing of antihypertensive drugs do not provide maximum coverage during this vulnerable period."( Pharmacokinetics of propranolol after single and multiple dosing with sustained release propranolol or propranolol CR (innopran XL) , a new chronotherapeutic formulation.
Frishman, WH; Manowitz, N; Sica, D,
)
0.13
"The present study demonstrates that octacosanoic acid is formed after incubation of fibroblast cultures with (3)H-octacosanol and after oral dosing with policosanol to rats."( In vitro and in vivo study of octacosanol metabolism.
Fernández, I; González, L; González, RM; Marrero, D; Más, R; Menéndez, R,
)
0.13
" Policosanol (5, 10, or 20 mg/d) was prescribed to patients eligible to receive cholesterol-lowering and/or antiplatelet drugs, with the dosage recommended according to their individual atherosclerotic risk."( A pharmacological surveillance study of the tolerability of policosanol in the elderly population.
Alvarez, E; Castańo, G; Deibis Orta, S; Diaz, A; Fernández, J; Fernández, S; Gamez, R; Illnait, J; Más, R; Mendoza, S; Valdés, F, 2004
)
0.32
" Rats were dosed orally for 7 days to determine (1) if HDN (induced by 2-propanol or D-limonene) altered the newer renal biomarkers and not BUN or creatinine, (2) if renal biomarkers could distinguish between HDN and oxidative stress-induced kidney injury (induced by potassium bromate), (3) sensitivity of HDN-induced renal biomarker changes relative to D-limonene dose, and (4) reversibility of HDN and renal biomarkers, using vehicle or 300 mg/kg/day D-limonene with 7 days of dosing and necropsies scheduled over the period of Days 8-85."( Renal biomarker changes associated with hyaline droplet nephropathy in rats are time and potentially compound dependent.
Bentley, P; Brott, DA; Cheatham, L; Fikes, J; Kinter, LB; Luo, W; McGrath, F; Nadella, MV; Thurman, D, 2013
)
0.39
" Baseline levels of acetaldehyde, acetone, methanol and ethanol could be measured in patients before dosing commenced and an increase in levels of some volatiles were observed in several neonates after receiving ethanol-containing medications."( GC-MS analysis of ethanol and other volatile compounds in micro-volume blood samples--quantifying neonatal exposure.
Cordell, RL; Hubbard, M; Monks, PS; Pandya, H; Turner, MA, 2013
)
0.39
" This dosage was selected on the basis of its expected -20% efficacy in reducing low-density lipoprotein-cholesterol."( Nutraceutical approach to moderate cardiometabolic risk: results of a randomized, double-blind and crossover study with Armolipid Plus.
Arnoldi, A; Bosisio, R; Calabresi, L; Gomaraschi, M; Macchi, C; Magni, P; Mombelli, G; Pavanello, C; Pazzucconi, F; Ruscica, M; Sirtori, CR,
)
0.13
" Because of the high heterogeneity, the better treatment effects observed in the Cuban studies and the inconsistent dose-response relationship, more clinical trials are needed to further confirm the efficacy of policosanol on dyslipidemia."( Efficacy and safety of sugarcane policosanol on dyslipidemia: A meta-analysis of randomized controlled trials.
Chen, G; Dong, H; Fang, K; Gong, J; Hu, M; Huang, Z; Jiang, S; Li, J; Lu, F; Qin, X; Wang, D; Yuan, F; Zhao, Y, 2018
)
0.48
"%, an enzyme dosage of 6 wt."( Highly Selective Synthesis of Monolaurin via Enzymatic Transesterification under Batch and Continuous Flow Conditions.
Chen, F; Liu, C; Xu, B; Zhang, G; Zhang, J; Zhao, F, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
protic solventA polar solvent that is capable of acting as a hydron (proton) donor.
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
propan-1-olsA primary alcohol based on a propan-1-olskeleton and its substituted derivatives.
short-chain primary fatty alcohol
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (11)

PathwayProteinsCompounds
Sulfate/Sulfite Metabolism620
Sulfite Oxidase Deficiency620
volatile esters biosynthesis (during fruit ripening)018
(S)-propane-1,2-diol degradation618
L-glutamate degradation II223
superpathway of Clostridium acetobutylicum acidogenic and solventogenic fermentation1855
pyruvate fermentation to acetone529
superpathway of Clostridium acetobutylicum solventogenic fermentation1444
superpathway of L-aspartate and L-asparagine biosynthesis730
volatile esters biosynthesis (during fruit ripening)220
lactose degradation III123
L-1,2-propanediol degradation013

Bioassays (33)

Assay IDTitleYearJournalArticle
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID23254Partition coefficient (logP) (chloroform)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID1594651Substrate activity at Geobacillus stearothermophilus DSM 2334 ADH expressed in Escherichia coli BL21 (DE3) assessed as Kcat in 50 mM HEPES buffer at pH 7.5 at 23 degC by MTT dye based Lineweaver-Burk plot analysis2019Bioorganic & medicinal chemistry letters, 06-15, Volume: 29, Issue:12
Characterization of the substrate scope of an alcohol dehydrogenase commonly used as methanol dehydrogenase.
AID1102450Fungitoxicity against Colletotrichum gloeosporioides assessed as mycelial growth inhibition by poisoned food technique2003Journal of agricultural and food chemistry, Aug-27, Volume: 51, Issue:18
Quantitative structure-fungitoxicity relationships of some monohydric alcohols.
AID1582364Lipophilicity, logP of the compound by 19F NMR-based method2020Journal of medicinal chemistry, 02-13, Volume: 63, Issue:3
Systematic Investigation of Lipophilicity Modulation by Aliphatic Fluorination Motifs.
AID23252Partition coefficient (logP) (benzene)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID237685Lipophilicity determined as logarithm of the partition coefficient in the alkane/water system2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
AID1134605Oil-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
AID1102840Antimicrobial activity against Staphylococcus aureus ATCC 25923 assessed as growth inhibition rate at 1.76 mg/l after 72 hr by spectrophotometry2004Journal of agricultural and food chemistry, Feb-25, Volume: 52, Issue:4
Volatile constituents from the leaves of Callicarpa japonica Thunb. and their antibacterial activities.
AID1102964Antimicrobial activity against Bacillus cereus ATCC 11778 assessed as growth inhibition rate at 1.76 mg/l after 72 hr by spectrophotometry2004Journal of agricultural and food chemistry, Feb-25, Volume: 52, Issue:4
Volatile constituents from the leaves of Callicarpa japonica Thunb. and their antibacterial activities.
AID603952In-vitro blood to lung partition coefficients of the compound, logP(lung) (human/rat)2008European journal of medicinal chemistry, Mar, Volume: 43, Issue:3
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
AID1102933Antimicrobial activity against Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 assessed as growth inhibition rate at 1.76 mg/l after 72 hr by spectrophotometry2004Journal of agricultural and food chemistry, Feb-25, Volume: 52, Issue:4
Volatile constituents from the leaves of Callicarpa japonica Thunb. and their antibacterial activities.
AID23253Partition coefficient (logP) (carbon tetrachloride)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID23255Partition coefficient (logP) (ether)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID159270Toxicity determined using Microtox Test1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Using theoretical descriptors in quantitative structure-activity relationships: some toxicological indices.
AID1102903Antimicrobial activity against Vibrio parahaemolyticus ATCC 33844 assessed as growth inhibition rate at 1.76 mg/l after 72 hr by spectrophotometry2004Journal of agricultural and food chemistry, Feb-25, Volume: 52, Issue:4
Volatile constituents from the leaves of Callicarpa japonica Thunb. and their antibacterial activities.
AID19262Aqueous solubility2000Bioorganic & medicinal chemistry letters, Jun-05, Volume: 10, Issue:11
Prediction of drug solubility from Monte Carlo simulations.
AID23251Partition coefficient (logP)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID26047logBB, log(C brain / C blood)1996Journal of medicinal chemistry, Nov-22, Volume: 39, Issue:24
Computation of brain-blood partitioning of organic solutes via free energy calculations.
AID603950In-vitro air to lung partition coefficients of the compound, logK(lung) (human/rat)2008European journal of medicinal chemistry, Mar, Volume: 43, Issue:3
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
AID1102809Antimicrobial activity against Escherichia coli O157:H7 ATCC 43894 assessed as growth inhibition rate at 1.76 mg/l after 72 hr by spectrophotometry2004Journal of agricultural and food chemistry, Feb-25, Volume: 52, Issue:4
Volatile constituents from the leaves of Callicarpa japonica Thunb. and their antibacterial activities.
AID603951In-vitro air to blood partition coefficients of the compound, logK(blood) (human/rat)2008European journal of medicinal chemistry, Mar, Volume: 43, Issue:3
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
AID101345Toxicity determined using Golden Orfe Fish Test1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Using theoretical descriptors in quantitative structure-activity relationships: some toxicological indices.
AID212400Toxicity determined using Tadpole Narcosis Test1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Using theoretical descriptors in quantitative structure-activity relationships: some toxicological indices.
AID1102871Antimicrobial activity against Listeria monocytogenes ATCC 19111 assessed as growth inhibition rate at 1.76 mg/l after 72 hr by spectrophotometry2004Journal of agricultural and food chemistry, Feb-25, Volume: 52, Issue:4
Volatile constituents from the leaves of Callicarpa japonica Thunb. and their antibacterial activities.
AID346025Binding affinity to beta cyclodextrin2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Convenient QSAR model for predicting the complexation of structurally diverse compounds with beta-cyclodextrins.
AID23256Partition coefficient (logP) (hexane)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID1594652Substrate activity at Geobacillus stearothermophilus DSM 2334 ADH expressed in Escherichia coli BL21 (DE3) assessed as Km in 50 mM HEPES buffer at pH 7.5 at 23 degC by MTT dye based Lineweaver-Burk plot analysis2019Bioorganic & medicinal chemistry letters, 06-15, Volume: 29, Issue:12
Characterization of the substrate scope of an alcohol dehydrogenase commonly used as methanol dehydrogenase.
AID1594653Substrate activity at Geobacillus stearothermophilus DSM 2334 ADH expressed in Escherichia coli BL21 (DE3) assessed as Kcat/Km ratio in 50 mM HEPES buffer at pH 7.5 at 23 degC by MTT dye based Lineweaver-Burk plot analysis2019Bioorganic & medicinal chemistry letters, 06-15, Volume: 29, Issue:12
Characterization of the substrate scope of an alcohol dehydrogenase commonly used as methanol dehydrogenase.
AID1134606Et2O-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
AID168703Inhibition of Rana pipiens muscle activity.1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Using theoretical descriptors in quantitative structure-activity relationships: some toxicological indices.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (2,924)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901676 (57.32)18.7374
1990's535 (18.30)18.2507
2000's342 (11.70)29.6817
2010's286 (9.78)24.3611
2020's85 (2.91)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 73.28

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index73.28 (24.57)
Research Supply Index8.10 (2.92)
Research Growth Index4.35 (4.65)
Search Engine Demand Index144.99 (26.88)
Search Engine Supply Index2.19 (0.95)

This Compound (73.28)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials170 (5.42%)5.53%
Reviews60 (1.91%)6.00%
Case Studies91 (2.90%)4.05%
Observational0 (0.00%)0.25%
Other2,814 (89.76%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]